MediPharm Labs Corp.
MEDIF
$0.04
$0.00-1.65%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.31M | 8.53M | 7.53M | 8.60M | 7.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.31M | 8.53M | 7.53M | 8.60M | 7.18M |
| Cost of Revenue | 6.44M | 6.10M | 4.62M | 5.84M | 4.83M |
| Gross Profit | 1.87M | 2.44M | 2.91M | 2.77M | 2.36M |
| SG&A Expenses | 3.27M | 5.18M | 3.28M | 3.09M | 4.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 137.20K | -56.40K | -115.70K | -90.70K | 165.70K |
| Total Operating Expenses | 9.88M | 11.25M | 7.84M | 8.88M | 9.09M |
| Operating Income | -1.57M | -2.72M | -305.90K | -276.50K | -1.90M |
| Income Before Tax | -1.56M | -2.72M | -269.70K | -1.23M | -2.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.56M | -2.72M | -269.70K | -1.23M | -2.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.56M | -2.72M | -269.70K | -1.23M | -2.03M |
| EBIT | -1.57M | -2.72M | -305.90K | -276.50K | -1.90M |
| EBITDA | -1.27M | -2.42M | -16.00K | 112.90K | -1.53M |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 420.76M | 415.35M | 415.12M | 411.83M | 411.07M |
| Average Diluted Shares Outstanding | 420.76M | 415.35M | 415.12M | 411.83M | 411.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |